Application no. and date | 17864975.2 (espacenet) (Federated) (European Patent Register), 20171013 | Patent/reg. no. and date | DK/EP 3533449, 20230712 | Publication date | 20190904 | Priority no. and date | JP 2016213072, 20161031 | EP pub. no. and date |
EP 3533449 20190904 | Effective date | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27 Kandanishiki-cho Chiyoda-ku Tokyo 101-8444, JP | Applicant ref. no. | PU279215DKQ | Inventor | MIYADERA, Kazutaka, c/o TAIHO PHARMACEUTICAL Co. Ltd. 3 Okubo
Tsukuba-shi Ibaraki 300-2611, JP, AOYAGI, Yoshimi, c/o TAIHO PHARMACEUTICAL Co. Ltd. 3 Okubo
Tsukuba-shi Ibaraki 300-2611, JP, HASAKO, Shinichi, c/o TAIHO PHARMACEUTICAL Co. Ltd. 3 Okubo
Tsukuba-shi Ibaraki 300-2611, JP | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) | Title | SELEKTIV HÆMMER AF EXON-20-INSERTIONsMUTANT EGFR | Int. application no. | JP2017037186 | Int. publication no. | WO2018079310 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|